Skip to content
10-Q

Quarterly Report

CNS Pharmaceuticals, Inc. CNSP

0001683168-25-008466

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 620.29K sh
Shares Diluted Q3 2025 · Sep 30, 2025 558.87K sh
Shares Diluted Q3 2025 · Sep 30, 2025 386.55K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 36.59K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 12.59K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$10.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$11.64M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $9.86M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $6.46M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.91M
Stockholders Equity Q3 2025 · Jun 30, 2025 $13.12M
Stockholders Equity Q3 2025 · Mar 31, 2025 $10.97M
Stockholders Equity Q3 2025 · Dec 31, 2024 $6.18M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.35M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$4.29M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$4.43M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$4.43M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.96M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.52M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.96M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.52M
Current Assets Q3 2025 · Sep 30, 2025 $11.39M
Current Assets Q3 2025 · Dec 31, 2024 $8.66M
Total Assets Q3 2025 · Sep 30, 2025 $11.87M
Total Assets Q3 2025 · Dec 31, 2024 $8.7M
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.76
Eps Diluted Q3 2025 · Sep 30, 2025 −$25.60
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$153.20
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$927.76
Eps Basic Q3 2025 · Sep 30, 2025 −$5.76
Eps Basic Q3 2025 · Sep 30, 2025 −$25.60
Eps Basic restated Q3 2025 · Sep 30, 2024 −$153.20
Eps Basic restated Q3 2025 · Sep 30, 2024 −$927.76
Sga Expense Q3 2025 · Sep 30, 2025 $1.06M
Sga Expense Q3 2025 · Sep 30, 2025 $3.39M
Sga Expense Q3 2025 · Sep 30, 2024 $1.38M
Sga Expense Q3 2025 · Sep 30, 2024 $3.91M
Rd Expense Q3 2025 · Sep 30, 2025 $2.2M
Rd Expense Q3 2025 · Sep 30, 2025 $6.61M
Rd Expense Q3 2025 · Sep 30, 2024 $4.24M
Rd Expense Q3 2025 · Sep 30, 2024 $7.79M
Net Income Q3 2025 · Sep 30, 2025 −$3.22M
Net Income Q3 2025 · Sep 30, 2025 −$9.89M
Net Income Q3 2025 · Jun 30, 2025 −$2.37M
Net Income Q3 2025 · Mar 31, 2025 −$4.3M
Net Income Q3 2025 · Sep 30, 2024 −$5.61M
Net Income Q3 2025 · Sep 30, 2024 −$11.68M
Net Income Q3 2025 · Jun 30, 2024 −$2.53M
Net Income Q3 2025 · Mar 31, 2024 −$3.54M
Operating Income Q3 2025 · Sep 30, 2025 −$3.25M
Operating Income Q3 2025 · Sep 30, 2025 −$10M
Operating Income Q3 2025 · Sep 30, 2024 −$5.63M
Operating Income Q3 2025 · Sep 30, 2024 −$11.7M